Scotiabank lowered the firm’s price target on Well Health (WHTCF) to C$6 from C$6.50 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WHTCF:
- Analyst Reiterates Buy on WELL Health, Citing Strong Core Performance, Structural Tailwinds and Strategic Value-Creation Initiatives
- WELL Health: Record Patient Volumes, Expanding Physician Base, and Emerging Margin Leverage Support Buy Rating
- WELL’s CYBERWELL Unifies Cyber Units and Launches AI-Driven CYDEcore Fusion Platform
- Well Health’s CYBERWELL launches CYDEcore Fusion platform
- WELL Health Taps AliveCor Partnership to Expand AI-Enabled Remote Cardiac Care in Canada